{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T06:07:13Z","timestamp":1764828433385},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,4]],"date-time":"2012-08-04T00:00:00Z","timestamp":1344038400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s00417-012-2112-7","type":"journal-article","created":{"date-parts":[[2012,8,3]],"date-time":"2012-08-03T05:43:49Z","timestamp":1343972629000},"page":"221-234","source":"Crossref","is-referenced-by-count":10,"title":["Physiological evidence for impairment in autosomal dominant optic atrophy at the pre-ganglion level"],"prefix":"10.1007","volume":"251","author":[{"given":"Aldina","family":"Reis","sequence":"first","affiliation":[]},{"given":"Catarina","family":"Mateus","sequence":"additional","affiliation":[]},{"given":"Teresa","family":"Viegas","sequence":"additional","affiliation":[]},{"given":"Ralph","family":"Florijn","sequence":"additional","affiliation":[]},{"given":"Arthur","family":"Bergen","sequence":"additional","affiliation":[]},{"given":"Eduardo","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Miguel","family":"Castelo-Branco","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2012,8,4]]},"reference":[{"key":"2112_CR1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0420.1996.tb00672.x","volume":"74","author":"B Kjer","year":"1996","unstructured":"Kjer B, Eiberg H, Kjer P, Rosenberg T (1996) Dominant optic atrophy (OPA1) mapped to chromosome 3q region, II: clinical and epidemiological aspects. Acta Ophthalmol Scand 74:3\u20137","journal-title":"Acta Ophthalmol Scand"},{"issue":"54","key":"2112_CR2","first-page":"1","volume":"164","author":"P Kjer","year":"1959","unstructured":"Kjer P (1959) Infantile optic atrophy with dominant mode of inheritance: a clinical and genetic study of 19 Danish families. Acta Opthalmol 164(54):1\u2013147","journal-title":"Acta Opthalmol"},{"key":"2112_CR3","first-page":"125","volume":"16","author":"B Batten","year":"1896","unstructured":"Batten B (1896) A family suffering from hereditary optic atrophy. Trans Ophthalmol Soc U K 16:125","journal-title":"Trans Ophthalmol Soc U K"},{"key":"2112_CR4","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/hmg\/3.6.977","volume":"3","author":"H Eiberg","year":"1994","unstructured":"Eiberg H, Kjer P, Rosenberg T (1994) Dominant optic atrophy (OPA1) mapped to chromosome 3q region, I: linkage analysis. Hum Mol Genet 3:977\u2013980","journal-title":"Hum Mol Genet"},{"key":"2112_CR5","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/jmg.32.12.951","volume":"32","author":"D Bonneau","year":"1995","unstructured":"Bonneau D, Souied E, Gerber S, Rozet JM, D\u2019Haens E, Journel H, Plessis G, Weissenbach J, Munnich A, Kaplan J (1995) No evidence of genetic heterogeneity in dominant optic atrophy. J Med Genet 32:951\u2013953","journal-title":"J Med Genet"},{"issue":"2","key":"2112_CR6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/79944","volume":"26","author":"C Alexander","year":"2000","unstructured":"Alexander C, Votruba M, Pesch UE, Thiselton DL, Mayer S, Moore A, Rodriguez M, Kellner U, Leo-Kottler B, Auburger G, Bhattacharya SS, Wissinger B (2000) OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet 26(2):211\u2013215","journal-title":"Nat Genet"},{"issue":"2","key":"2112_CR7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/79936","volume":"26","author":"C Delettre","year":"2000","unstructured":"Delettre C, Lenaers G, Griffoin JM, Gigarel N, Lorenzo C, Belenguer P, Pelloquin L, Grosgeorge J, Turc-Carel C, Perret E, Astarie-Dequeker C, Lasquellec L, Arnaud B, Ducommun B, Kaplan J, Hamel CP (2000) Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 26(2):207\u2013210","journal-title":"Nat Genet"},{"key":"2112_CR8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/jmg.2007.054270","volume":"46","author":"P Yu-Wai-Man","year":"2009","unstructured":"Yu-Wai-Man P, Griffiths PG, Hudson G, Chinnery PF (2009) Inherited mitochondrial optic neuropathies. J Med Genet 46:145\u2013158","journal-title":"J Med Genet"},{"issue":"3","key":"2112_CR9","first-page":"517","volume":"140","author":"NJ Newman","year":"2005","unstructured":"Newman NJ (2005) Hereditary optic neuropathies: from the mitochondria to the optic nerve. Am J Ophthalmol 140(3):517\u2013523","journal-title":"Am J Ophthalmol"},{"key":"2112_CR10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1023\/A:1024441302074","volume":"26","author":"M Votruba","year":"2003","unstructured":"Votruba M, Aijaz S, Moore AT (2003) A review of primary hereditary optic neuropathies. J Inherit Metab Dis 26:209\u2013227","journal-title":"J Inherit Metab Dis"},{"key":"2112_CR11","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0002-9394(14)73589-5","volume":"115","author":"MD Elliot","year":"1993","unstructured":"Elliot MD, Traboulsi EI, Maumenee IH (1993) Visual prognosis in autosomal dominant optic atrophy (Kjer type). Am J Ophthalmol 115:360\u2013367","journal-title":"Am J Ophthalmol"},{"key":"2112_CR12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archopht.116.3.351","volume":"116","author":"M Votruba","year":"1998","unstructured":"Votruba M, Fitzke FW, Holder GE, Carter A, Bhattacharya SS, Moore AT (1998) Clinical features in affected individuals from 21 pedigrees with dominant optic atrophy. Arch Ophthalmol 116:351\u2013358","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"2112_CR13","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1001\/archopht.1979.01020020248013","volume":"97","author":"LB Kline","year":"1979","unstructured":"Kline LB, Glaser JS (1979) Dominant optic atrophy. The clinical profile. Arch Ophthalmol 97(9):1680\u20131686","journal-title":"Arch Ophthalmol"},{"key":"2112_CR14","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1755-3768.1970.tb08211.x","volume":"48","author":"CC Kok-van Alphen","year":"1970","unstructured":"Kok-van Alphen CC (1970) Four families with the dominant infantile from of optic nerve atrophy. Acta Ophthalmol 48:905\u2013916","journal-title":"Acta Ophthalmol"},{"key":"2112_CR15","first-page":"221","volume-title":"Evoked potentials III","author":"GE Holder","year":"1987","unstructured":"Holder GE (1987) Abnormalities of the pattern ERG in optic nerve lesions: changes specific for proximal retinal dysfunction. In: Barber C, Blum T (eds) Evoked potentials III. Butterworths, London, pp 221\u2013224"},{"issue":"3\u20134","key":"2112_CR16","first-page":"217","volume":"95","author":"GE Holder","year":"1999","unstructured":"Holder GE, Votruba M, Carter AC, Bhattacharya SS, Fitzke FW, Moore AT (1999) Electrophysiological findings in dominant optic atrophy (DOA) linking to the OPA1 locus on chromosome 3q 28-qter. Doc Ophthalmol 95(3\u20134):217\u2013228","journal-title":"Doc Ophthalmol"},{"issue":"1","key":"2112_CR17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ophtha.2010.04.022","volume":"118","author":"JC Booij","year":"2011","unstructured":"Booij JC, Bakker A, Kulumbetova J, Moutaoukil Y, Smeets B, Verheij J, Kroes HY, Klaver CC, van Schooneveld M, Bergen AA, Florijn RJ (2011) Simultaneous mutation detection in 90 retinal disease genes in multiple patients using a custom-designed 300-kb retinal resequencing chip. Ophthalmology 118(1):160\u2013167","journal-title":"Ophthalmology"},{"key":"2112_CR18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1001\/archopht.1995.01100030081025","volume":"113","author":"MR Hee","year":"1995","unstructured":"Hee MR, Izatt JA, Swanson EA, Huang D, Schuman JS, Lin CP, Puliafito CA, Fujimoto JG (1995) Optical coherence tomography of the human retina. Arch Ophtahlmol 113:325\u2013332","journal-title":"Arch Ophtahlmol"},{"key":"2112_CR19","first-page":"1994","volume":"37","author":"R Zeimer","year":"1996","unstructured":"Zeimer R, Shaidi M, Mori M, Zou S, Asrani S (1996) A new method for rapid mapping of the retinal thickness at the posterior pole. Invest Ophthalmol Vis Sci 37:1994\u20132001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2112_CR20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ajo.2009.08.037","volume":"149","author":"DF Kiernan","year":"2010","unstructured":"Kiernan DF, Mieler WF, Hariprasad SM (2010) Spectral-domain optical coherence tomography: a comparison of modern high-resolution retinal imaging systems. Am J Ophthalmol 149:18\u201331","journal-title":"Am J Ophthalmol"},{"key":"2112_CR21","first-page":"277","volume":"131","author":"AP Henderson","year":"2008","unstructured":"Henderson AP, Trip SA, Schlottmann PG, Altmann DR, Garway-Heath DF, Plant GT, Miller DH (2008) An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography. Brain 131:277\u2013287","journal-title":"Brain"},{"key":"2112_CR22","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/0042-6989(94)90203-8","volume":"34","author":"BC Regan","year":"1994","unstructured":"Regan BC, Reffin JP, Mollon JD (1994) Luminance noise and the rapid determination of discrimination ellipses in colour deficiency. Vis Res 34:1279\u20131299","journal-title":"Vis Res"},{"key":"2112_CR23","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/archopht.123.7.944","volume":"123","author":"SH Campos","year":"2005","unstructured":"Campos SH, Forjaz V, Kozak LR, Silva E, Castelo-Branco M (2005) Quantitative phenotyping of chromatic dysfunction in Best macular distrophy. Arch Ophthalmol 123:944\u2013949","journal-title":"Arch Ophthalmol"},{"key":"2112_CR24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1167\/iovs.03-0815","volume":"45","author":"M Castelo-Branco","year":"2004","unstructured":"Castelo-Branco M, Faria P, Forjaz V, Kozak LR, Azevedo H (2004) Simultaneous comparison of relative damage to chromatic pathways in ocular hypertension and glaucoma: correlation with clinical measures. Invest Ophthalmol Vis Sci 45:499\u2013505","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2112_CR25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0161-6420(99)00026-3","volume":"107","author":"J Morales","year":"2000","unstructured":"Morales J, Weitzmann ML, Gonz\u00e1lez de la Rosa M (2000) Comparison between tendency-oriented perimetry (TOP) and Octopus threshold perimetry. Ophthalmology 107:134\u2013142","journal-title":"Ophthalmology"},{"key":"2112_CR26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10633-007-9053-1","volume":"114","author":"GE Holder","year":"2007","unstructured":"Holder GE, Brigell MG, Hawlina M, Meigen T, Vaegan, Bach M, International Society for Clinical Electrophysiology of Vision (2007) ISCEV standard for clinical pattern electroretinography\u20142007 update. Doc Ophthalmol 114:111\u2013116","journal-title":"Doc Ophthalmol"},{"key":"2112_CR27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10633-009-9195-4","volume":"120","author":"JV Odom","year":"2010","unstructured":"Odom JV, Bach M, Brigell M, Holder GE, McCulloch DL, Tormene AP, Vaegan (2010) ISCEV standard for clinical visual evoked potentials (2009 update). Doc Ophthalmol 120:111\u2013119","journal-title":"Doc Ophthalmol"},{"key":"2112_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10633-011-9296-8","volume":"124","author":"D Hood","year":"2011","unstructured":"Hood D, Bach M, Brigell M, Keating D, Kondo M, Lyons JS, Marmor MF, McCulloch DL, Palmowski-Wolfe AM, International Society for Clinical Electrophysiology of Vision (2011) ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 Edition). Doc Ophthalmol 124:1\u201313","journal-title":"Doc Ophthalmol"},{"key":"2112_CR29","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1023\/A:1015235617673","volume":"104","author":"DC Hood","year":"2002","unstructured":"Hood DC, Zhang X, Hong JE, Chen CS (2002) Quantifying the benefits of additional channels of multifocal VEP recording. Doc Ophthalmol 104:303\u2013320","journal-title":"Doc Ophthalmol"},{"key":"2112_CR30","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/S0161-6420(00)00367-5","volume":"107","author":"AI Klistorner","year":"2000","unstructured":"Klistorner AI, Graham SL (2000) Objective perimetry in glaucoma. Ophthalmology 107:2283\u20132299","journal-title":"Ophthalmology"},{"issue":"3","key":"2112_CR31","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ophtha.2010.07.029","volume":"118","author":"P Yu-Wai-Man","year":"2011","unstructured":"Yu-Wai-Man P, Shankar SP, Biousse V, Miller NR, Bean LJ, Coffee B, Hegde M, Newman NJ (2011) Genetic screening for OPA1 and OPA3 mutations in patients with suspected inherited optic neuropathies. Ophthalmology 118(3):558\u2013563","journal-title":"Ophthalmology"},{"issue":"6","key":"2112_CR32","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s00439-001-0633-y","volume":"109","author":"C Delettre","year":"2001","unstructured":"Delettre C, Griffoin JM, Kaplan J, Dollfus H, Lorenz B, Faivre L, Lenaers G, Belenguer P, Hamel CP (2001) Mutation spectrum and splicing variants in the OPA1 gene. Hum Genet 109(6): 584\u2013591","journal-title":"Hum Genet"},{"issue":"6","key":"2112_CR33","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0197-0186(01)00129-2","volume":"40","author":"V Carelli","year":"2002","unstructured":"Carelli V, Ross-Cisneros FN, Sadun AA (2002) Optic nerve degeneration and mitochondrial dysfunction: genetic and acquired optic neuropathies. Neurochem Int 40(6):573\u2013584","journal-title":"Neurochem Int"},{"issue":"11","key":"2112_CR34","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1167\/iovs.03-1261","volume":"45","author":"UE Pesch","year":"2004","unstructured":"Pesch UE, Fries JE, Bette S, Kalbacher H, Wissinger B, Alexander C, Kohler K (2004) OPA1, the disease gene for autosomal dominant optic atrophy, is specifically expressed in ganglion cells and intrinsic neurons of the retina. Invest Ophthalmol Vis Sci 45(11):4217\u20134225","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"2112_CR35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.preteyeres.2003.10.003","volume":"23","author":"V Carelli","year":"2004","unstructured":"Carelli V, Ross-Cisneros FN, Sadun AA (2004) Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res 23(1):53\u201389","journal-title":"Prog Retin Eye Res"},{"key":"2112_CR36","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/0002-9394(79)90565-8","volume":"88","author":"PB Johnston","year":"1979","unstructured":"Johnston PB, Gaster RN, Smith VC, Tripathi RC (1979) A clinicopathological study of autosomal dominant optic atrophy. Am J Ophthalmol 88:868\u2013875","journal-title":"Am J Ophthalmol"},{"key":"2112_CR37","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1755-3768.1983.tb01424.x","volume":"61","author":"P Kjer","year":"1983","unstructured":"Kjer P, Jensen OA, Klinken L (1983) Histopathology of eye, optic nerve and brain in a case of dominant optic atrophy. Acta Opthalmol 61:300\u2013312","journal-title":"Acta Opthalmol"},{"issue":"5","key":"2112_CR38","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/eye.2011.2","volume":"25","author":"P Yu-Wai-Man","year":"2011","unstructured":"Yu-Wai-Man P, Bailie M, Atawan A, Chinnery PF, Griffiths PG (2011) Pattern of retinal ganglion cell loss in dominant optic atrophy due to OPA1 mutations. Eye 25(5):596\u2013602","journal-title":"Eye"},{"issue":"10","key":"2112_CR39","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.ophtha.2011.02.027","volume":"118","author":"P Barboni","year":"2011","unstructured":"Barboni P, Savini G, Parisi V, Carbonelli M, La Morgia C, Maresca A, Sadun F, De Negri AM, Carta A, Sadun AA, Carelli V (2011) Retinal nerve fiber layer thickness in dominant optic atrophy measurements by optical coherence tomography and correlation with age. Ophthalmology 118(10):2076\u20132080","journal-title":"Ophthalmology"},{"issue":"4","key":"2112_CR40","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1350-9462(00)00030-6","volume":"20","author":"GE Holder","year":"2001","unstructured":"Holder GE (2001) Pattern electroretinography (PERG) and an integrated approach to visual pathway diagnosis. Prog Retin Eye Res 20(4):531\u2013561","journal-title":"Prog Retin Eye Res"},{"issue":"11","key":"2112_CR41","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/sj.eye.6701573","volume":"18","author":"GE Holder","year":"2004","unstructured":"Holder GE (2004) Electrophysiological assessment of optic nerve disease. Eye 18(11):1133\u20131143","journal-title":"Eye"},{"issue":"1","key":"2112_CR42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/WCO.0b013e328320264c","volume":"22","author":"GE Holder","year":"2009","unstructured":"Holder GE, Gale RP, Acheson JF, Robson AG (2009) Electrodiagnostic assessment in optic nerve disease. Curr Opin Neurol 22(1):3\u201310","journal-title":"Curr Opin Neurol"},{"key":"2112_CR43","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0042-6989(98)00187-4","volume":"39","author":"MC Wescott","year":"1999","unstructured":"Wescott MC, Fitzke FW, Crabb DP, Hitchings RA (1999) Characteristics of frequency-of-seeing curves for a motion stimulus in glaucoma eyes, glaucoma suspect eyes, and normal eyes. Vis Res 39:631\u2013639","journal-title":"Vis Res"},{"key":"2112_CR44","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00415-011-6008-y","volume":"258","author":"A Reis","year":"2011","unstructured":"Reis A, Mateus C, Mac\u00e1rio MC, de Abreu JR, Castelo-Branco M (2011) Independent patterns of damage to retinocortical pathways in multiple sclerosis without a previous episode of optic neuritis. J Neurol 258:1695\u20131704","journal-title":"J Neurol"},{"key":"2112_CR45","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.visres.2007.10.018","volume":"48","author":"MF Silva","year":"2008","unstructured":"Silva MF, Maia-Lopes S, Mateus C, Guerreiro M, Sampaio J, Faria P, Castelo-Branco M (2008) Retinal and cortical patterns of spatial anisotropy in contrast sensitivity tasks. Vis Res 48:127\u2013135","journal-title":"Vis Res"},{"key":"2112_CR46","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1167\/iovs.03-1093","volume":"45","author":"S Aijaz","year":"2004","unstructured":"Aijaz S, Erskine L, Jeffery G, Bhattacharya SS, Votruba M (2004) Developmental expression profile of the optic atrophy gene product: OPA1 is not localized exclusively in the mammalian retinal ganglion cell layer. Invest Ophthalmol Vis Sci 45:1667\u20131673","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"2112_CR47","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1167\/iovs.07-0024","volume":"48","author":"Y Ito","year":"2007","unstructured":"Ito Y, Nakamura M, Yamakoshi T, Lin J, Yatsuya H, Terasaki H (2007) Reduction of inner retinal thickness in patients with autosomal dominant optic atrophy associated with OPA1 mutations. Invest Ophthalmol Vis Sci 48(9):4079\u20134086","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"2112_CR48","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1755-3768.2008.01469.x","volume":"88","author":"D Milea","year":"2010","unstructured":"Milea D, Sander B, Wegener M, Jensen H, Kjer B, J\u00f8rgensen TM, Lund-Andersen H, Larsen M (2010) Axonal loss occurs early in dominant optic atrophy. Acta Ophthalmol 88(3):342\u2013346","journal-title":"Acta Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-012-2112-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-012-2112-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-012-2112-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:48:20Z","timestamp":1559072900000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-012-2112-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,4]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["2112"],"URL":"https:\/\/doi.org\/10.1007\/s00417-012-2112-7","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,4]]}}}